CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia

Navy General Hospital, Beijing

Status: Enrolling

Conditions: Acute Leukemia

Study type: Observational

Funder types: Other

Identifiers

NCT04157569

NavyGHB-006

Details and patient eligibility

About

This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL

Full description

This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .

Enrollment: 200 estimated patients

Sex: All

Ages: 60 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent
• Male
• not pregnant female
• patients >=60 years old
• Diagnosis of acute leukemia

Exclusion criteria

• Pregnancy
• HIV positive
• patients >=100 years old